Efficacy of peptide and nonpeptidic agonists at the cloned human delta opioid receptor.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D001667:Binding, Competitive / Q000187:drug effects; D016466:CHO Cells; D003001:Cloning, Molecular; D006224:Cricetinae; D000242:Cyclic AMP / Q000096:biosynthesis; D020881:Enkephalin, D-Penicillamine (2,5)-; D004745:Enkephalins / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D018847:Opioid Peptides / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D017465:Receptors, Opioid, delta / Q000819:agonists*; D011994:Recombinant Proteins
D000700:Analgesics; D001549:Benzamides; D004745:Enkephalins; D018847:Opioid Peptides; D010879:Piperazines; D011804:Quinolines; D017465:Receptors, Opioid, delta; D011994:Recombinant Proteins; C094142:TAN 67; C088464:4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide; D020881:Enkephalin, D-Penicillamine (2,5)-; D000242:Cyclic AMP